Ozempic Advantages: Higher absorption efficiency, strong appetite suppression, weekly convenience, widely recognized for weight management support
First approved for type 2 diabetes as Ozempic, the higher-dose Wegovy is intended for chronic weight management, delivering semaglutide at 15-20% of the body weight. It acts on GLP-1 receptors in the pancreas, promoting insulin secretion and reducing glucagon, which regulates blood sugar
Application: Apply clean skin and gently pat in with fingertips
Novo Nordisks official page on compounded semaglutide information states that these compounded medicines might use semaglutide salts like sodium or acetate instead of the specific base form found in Wegovy
Performance margin is expected between 46% and 47.5%, suggesting operating leverage continues to improve even as manufacturing scales rapidly